Peter Sprietsma
Associate - Attorney at Law
Peter Sprietsma, attorney at law, is based in our Amsterdam office and provides counsel on class actions, corporate and commercial litigation.
Peter has extensive experience with class action litigation and broader corporate and commercial disputes. He advises and represents clients inside and outside of court. This includes experience litigating in English before the Netherlands Commercial Court (NCC). Peter regularly publishes on class actions in Dutch academic legal journals. Peter previously supported clients in the investment funds sector.
Recent matters Peter has worked on include representing:
• A group of car dealers in various Dutch class actions against multiple claim organisations relating to diesel emission devices in cars;
• The former CEO of Airbus SE in a Dutch class action regarding shareholders’ claims;
• A contract research organisation in a suit brought by a pharmaceutical company regarding data management in a clinical trial (in English before the NCC and NCCA).
Work highlights
Contributions
Memberships
Qualifications
Publications
Peter Sprietsma
Associate - Attorney at Law
Peter.Sprietsma@loyensloeff.com
Amsterdam
Dutch, English
<p>Peter Sprietsma, attorney at law, is based in our Amsterdam office and provides counsel on class actions, corporate and commercial litigation.</p>
Peter has extensive experience with class action litigation and broader corporate and commercial disputes. He advises and represents clients inside and outside of court. This includes experience litigating in English before the Netherlands Commercial Court (NCC). Peter regularly publishes on class actions in Dutch academic legal journals. Peter previously supported clients in the investment funds sector.
Recent matters Peter has worked on include representing:
• A group of car dealers in various Dutch class actions against multiple claim organisations relating to diesel emission devices in cars;
• The former CEO of Airbus SE in a Dutch class action regarding shareholders’ claims;
• A contract research organisation in a suit brought by a pharmaceutical company regarding data management in a clinical trial (in English before the NCC and NCCA).